Chemical Component Summary

Name1-METHYL-9-[12-(9-METHYLPHENAZIN-10-IUM-1-YL)-12-OXO-2,11-DIAZA-5,8-DIAZONIADODEC-1-ANOYL]PHENAZIN-10-IUM
Identifiers2-[(9-methylphenazin-10-ium-1-yl)carbonylamino]ethyl-[2-[2-[(9-methylphenazin-10-ium-1-yl)carbonylamino]ethylazaniumyl]ethyl]azanium
FormulaC34 H38 N8 O2
Molecular Weight590.718
TypeNON-POLYMER
Isomeric SMILESCc1cccc2c1[nH+]c3c(cccc3n2)C(=O)NCC[NH2+]CC[NH2+]CCNC(=O)c4cccc5c4[nH+]c6c(cccc6n5)C
InChIInChI=1S/C34H34N8O2/c1-21-7-3-11-25-29(21)41-31-23(9-5-13-27(31)39-25)33(43)37-19-17-35-15-16-36-18-20-38-34(44)24-10-6-14-28-32(24)42-30-22(2)8-4-12-26(30)40-28/h3-14,35-36H,15-20H2,1-2H3,(H,37,43)(H,38,44)/p+4
InChIKeySFOADSRLCHRTKT-UHFFFAOYSA-R

Chemical Details

Formal Charge4
Atom Count82
Chiral Atom Count0
Bond Count87
Aromatic Bond Count32

Drug Info: DrugBank

DrugBank IDDB06364 
NameXR5944
Groups investigational
DescriptionXR5944 is a DNA bis-intercalating anticancer drug. It has both intercalating and antineoplastic activities.
SynonymsXR5944
IndicationInvestigated for use/treatment in solid tumors.
CategoriesHeterocyclic Compounds, Fused-Ring
CAS number343247-32-5

Related Resource References

Resource NameReference
PubChem 449155